Drugstores group sues Delaware over Medicaid cutbacks

Walgreen Co.'s member organization in Delaware has "filed a suit against the state to put a stop to Medicaid rate cuts" just one week after "Walgreens announced it will stop filling prescriptions of brand-name medications for patients on Medicaid" in Delaware, the News Journal reports.

The lawsuit was filed in U.S. District Court by the National Community Pharmacists Association and the National Association of Chain Drug Stores, whose members include Rite Aid, CVS, Wal-Mart and Target, in addition to Walgreens. The groups say "the new rates will lead to more pharmacies closing their doors to Medicaid clients. Gov. Jack Markell, D-Del., "said in a statement that the suit will not intimidate his administration into paying Walgreens higher reimbursement rates."

A similar suit was filed in Washington state after the government announced a plan to cut reimbursement rates for brand-name prescriptions. The state "renegotiated a different rate" after a federal judge "temporarily suspended the plan" (Ratnayake, 6/12).

Meanwhile, Time reports that "in the past decade, more and more pharmacies like CVS and Walgreens, supermarkets such as Kroger and Publix and big-box stores like Wal-Mart have made space for clinics that treat minor ailments, administer vaccines and examine kids who need medical forms to enroll in camp." The retail health clinics often provide cheap treatment for the uninsured and quick service for those who can't get an appointment with a regular physician. The clinics are also money-makers for the drug stores. "Doctors have emerged as the biggest critics of the new trend, because they fear that patients will visit clinics for the treatment of minor ailments, a major source of doctor revenue, and they "will be left with only complicated cases that yield less profit." "In 2007, the American Medical Association called for an investigation into retail clinics, arguing that the drugstores, which position clinics directly adjacent to pharmacies, have a conflict of interest" (Pickert, 6/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

  1. HARVEY  GROVE HARVEY GROVE United States says:

    The wording of the statement by Walgreen leaves a lot to be desired. For instance..... their refusal to fill brand name prescriptions might be acceptable if they also added, "wherever there are no generics of the same drug".

    There are many drugs for which there is absolutely NO GENERIC equivalent, consquently, are they saying they will let the patient die (many drugs are for life saving heart conditions, or anti-biotics for infections that are resistant to generic drugs and only a brand name product works.)

    I have a condition that does not respond to a generic version. Also if I take the generic version it causes me to have seizures. The branded product must be slightly different as it works without the side effect of seizures. This is a side effect that is potentially fatal to me and those who may be around me when it happens. Walgreens is playing G-D with me.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
More than half of all US adults are eligible for semaglutide therapy